Chemo-bacterial synthesis of conjugatable glycosaminoglycans

Carbohydr Polym. 2017 Jul 1:167:123-128. doi: 10.1016/j.carbpol.2017.03.026. Epub 2017 Mar 10.

Abstract

Conjugatable glycosaminoglycans hold promise for medical applications involving the vectorization of specific molecules. Here, we set out to produce bacterial chondroitin and heparosan from a conjugatable precursor using metabolically engineered Escherichia coli strains. The major barrier to this procedure was the glucuronylation of a lactosyl acceptor required for polymerization. To overcome this barrier, we designed E. coli strains expressing mouse β-1,3-glucuronyl transferase and E. coli K4 chondroitin and K5 heparosan synthases. These engineered strains were cultivated at high density in presence of a lactose-furyl precursor. Enzymatic polymerization occurred on the lactosyl precursor resulting in small chains ranging from 15 to 30kDa that accumulated in the cytoplasm. Furyl-terminated polysaccharides were produced at a gram-per-liter scale, a yield similar to that reported for conventional strains. Their efficient conjugation using a Diels-Alder cycloaddition reaction in aqueous and catalyst-free conditions was also confirmed using N-methylmaleimide as model dienophile.

Keywords: Chondroitin; Click chemistry; Enzymatic synthesis; Heparosan; Recombinant E. coli.

MeSH terms

  • Animals
  • Chondroitin / biosynthesis
  • Disaccharides / biosynthesis
  • Escherichia coli / metabolism*
  • Glucuronosyltransferase / metabolism*
  • Glycosaminoglycans / biosynthesis*
  • Metabolic Engineering*
  • Mice

Substances

  • Disaccharides
  • Glycosaminoglycans
  • heparosan
  • Chondroitin
  • Glucuronosyltransferase